학술논문
197P Clinical benefit of HER2-targeted therapies versus prior chemotherapy in refractory HER2 expressing and mutant gastrointestinal malignancies
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S260-S260
Subject
Language
ISSN
0923-7534